Table 2.
S. baicalensis/S. radix/Flavones | Concentration | NSCLC Cell Lines Target | Activity | Molecular Mechanism Target | Reference |
---|---|---|---|---|---|
S. baicalensis | 250, 500 µg/mL | A549 | Inhibition of cell motility/proliferation, induction of G1 phase arrest | cyclinD1, CDK4, MMP2 ↓ | [51] |
S. radix | 750 µg/mL | H2087, H358 | Induction of apoptosis and autophagy | caspase 3, PARP, LC3-II/LC3-I, AMPK ↑ mTOR ↓ |
[52] |
S. radix/baicalein/wogonin | 42.3 μg/mL | A549 | Inhibition of cell proliferation/invasion, induction of S phase arrest | cyclinD1 ↓, P53 ↑ | [53] |
S. baicalensis/baicalein/baicalin/wogonin | 29.8, 27.5, 16.7 μg/mL | SK-LU-1, A549, SK-MES-1 | Induction of apoptosis and S phase arrest | Bax, P53 ↑ cyclinA ↓ |
[54] |
S. baicalensis/baicalein/baicalin/wogonin | 1, 10, 50 µM | A549, H1299 | Anti-metastatic, anti-inflammatory, induction of apoptosis | Bax ↑ MMP2,MMP9, caspase-3, bcl-2/bax, bcl-2, NF-κB p65, TNF-α, IL-6, IκB-α ↓ |
[55] |
S. baicalensis/baicalein/baicalin/wogonin | 10, 40, 200 μM | A549, H1299 | Inhibition of cell migration/invasion, Id1 inhibition, anti-angiogenesis | VEGF-A, N-cadherin, vimentin, a7nAChR, Akt/Src ↓ E-cadherin ↑ |
[41] |
Baicalein | 40 µmol/L | A549, H460 | Inhibition of cell proliferation, induction of apoptosis | PI3K/Akt, miR-424-3p ↓ | [56] |
Baicalein | 40 µmol/L | A549 | Inhibition of cell motility/viability, anti-angiogenesis | PI3K, MMP2, MMP9 MMP14, VE-cadherin, RhoA/ROCK ↓ | [57] |
Baicalein | 100, 200 µM | A549, H1299 | Induction of autophagy | MAP4K3, mTOR ↓ | [58] |
Baicalein | 10, 40 µmol/L | A549, H1299 | Inhibition of cell invasion/metastasis | ezrin tension transduction, leader cells production, iNOS ↓ | [59] |
Baicalein | 1, 10, 100 µM | A549, H460, SKMES1 | Anti-angiogenesis | VEGF-A, FGFR-2, RB-1 ↓ | [42] |
Baicalein | 80 µmol/L | A549, H1299 | Inhibition of cell proliferation/invasion, Notch1 and hes-1 expression |
cyclinD1, CDK1, N-cadherin, vimentin ↓ E-cadherin ↑ |
[60] |
Baicalein | 10 µM | A549 | Anti-proliferative | N-cadherin, vimentin, Src/Id1 ↓ E-cadherin ↑ |
[43] |
Baicalin | 100 µM | A549, H2009 | TRAIL-induced apoptosis | MAPK, ROS ↑ | [61] |
Baicalin | 2, 4, 8 μg/mL | A549/DDP | Inhibition of cell proliferation/invasion | MARK2 mRNA, p-Akt ↓ | [62] |
Baicalin | 25, 50, 100 µM | H441, H1975, H1299 | Inhibition of cell proliferation/invasion | PBK/TOPK ↓ | [63] |
Baicalin | 20, 40, 80 µmol/L | A549, H1299 | Inhibition of cell proliferation/invasion induction of apoptosis | SIRT1/AMPK ↑ MMP2, MMP9 ↓ |
[64] |
Wogonin | 20 µM | A549 | Induction of apoptosis, cisplatin-induced cell death | caspase 3, PARP, ROS ↑ | [65] |
Wogonin | 20 µM | A549 | Inhibition of cell migration/metastasis, anti-inflammatory | (IL-6)-induced EMT, N-cadherin, vimentin, Snail, Twist, STAT3 ↓ E-cadherin ↑ |
[66] |
Wogonin | 15 μg/mL | A549 | Inhibition of cell proliferation, glucose metabolism alteration | LDH, ATP synthesis ↓ | [67] |
Wogonin | 50 µM | A549, A427 | Induction of apoptosis and autophagy | caspases 8/9/3,ROS, LC3II ↑ | [68] |
Wogonin | 35 μg/mL | A549 | Inhibition of cell viability, induction of apoptosis | HDAC1/2, Skp2, Fbw7, GSK3b ↓ | [69] |
Wogonin | 10 µM | A549 | Cell cycle arrest, senescence, apoptosis | APAF1, Bax, p21, PML, GADD45A, YPEL3 ↑ SGK1 ↓ |
[70] |
Wogonoside | 80 μM | A549 | Induction of apoptosis, cell cycle arrest | caspases 3/9, Bax, mitochondrial cytochrome c, AMPK ↑ Bcl-2, mTOR ↓ |
[71] |
Wogonin | 60, 100, 200 μM | DMEM | Anti-proliferative | caspases 3/9 ↑ | [72] |
Oroxylin A | 40 μM | H460 | Anti-inflammatory | Tregs, TGFβ, Smad3, ERK1/2, JNK, P38, NF-κB/p65, IKKα, IKKβ ↓ | [73] |
Oroxylin A | 16 μM | A549,95-D | Anti-invasive/migration | Snail, ERK/GSK-3β, CD44v6, MMP-9, vimentin ↓ E-cadherin ↑ |
[74] |
Oroxylin A | 120 μM | A549 | Anti-invasion, glucose metabolism alteration | Src/PI3K/AKT, ATP synthesis, lactic acid formation, HK II ↓ | [75] |
Oroxylin A | 50 μmol/L | H460 | Suppression of XPC | HIF-1α ↓ | [76] |
(↓) decrease, (↑) increase.